1. Home
  2. EICC vs ORMP Comparison

EICC vs ORMP Comparison

Compare EICC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EICC
  • ORMP
  • Stock Information
  • Founded
  • EICC N/A
  • ORMP 2002
  • Country
  • EICC United States
  • ORMP United States
  • Employees
  • EICC N/A
  • ORMP N/A
  • Industry
  • EICC
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • EICC
  • ORMP Health Care
  • Exchange
  • EICC Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • EICC N/A
  • ORMP 90.2M
  • IPO Year
  • EICC N/A
  • ORMP N/A
  • Fundamental
  • Price
  • EICC $25.10
  • ORMP $2.41
  • Analyst Decision
  • EICC
  • ORMP Hold
  • Analyst Count
  • EICC 0
  • ORMP 1
  • Target Price
  • EICC N/A
  • ORMP N/A
  • AVG Volume (30 Days)
  • EICC 18.7K
  • ORMP 99.1K
  • Earning Date
  • EICC 01-01-0001
  • ORMP 11-06-2025
  • Dividend Yield
  • EICC 7.96%
  • ORMP N/A
  • EPS Growth
  • EICC N/A
  • ORMP N/A
  • EPS
  • EICC 0.55
  • ORMP N/A
  • Revenue
  • EICC $51,224,692.00
  • ORMP $2,000,000.00
  • Revenue This Year
  • EICC $39.61
  • ORMP N/A
  • Revenue Next Year
  • EICC $27.28
  • ORMP N/A
  • P/E Ratio
  • EICC $23.44
  • ORMP N/A
  • Revenue Growth
  • EICC 68.61
  • ORMP N/A
  • 52 Week Low
  • EICC $23.75
  • ORMP $1.82
  • 52 Week High
  • EICC $25.25
  • ORMP $3.09
  • Technical
  • Relative Strength Index (RSI)
  • EICC 45.19
  • ORMP 71.70
  • Support Level
  • EICC $25.07
  • ORMP $2.17
  • Resistance Level
  • EICC $25.28
  • ORMP $2.45
  • Average True Range (ATR)
  • EICC 0.06
  • ORMP 0.06
  • MACD
  • EICC 0.00
  • ORMP 0.03
  • Stochastic Oscillator
  • EICC 24.17
  • ORMP 88.24

About EICC Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: